MedPath

Effects of complications on onset of nonfatal events and life prognosis in patients with chronic kidney disease

Not Applicable
Conditions
Chronic kidney disease(CKD)
Registration Number
JPRN-UMIN000030071
Lead Sponsor
Saitama Tsukinomori Clinic
Brief Summary

Seventy-two CKD patients with renal anemia were divided into three groups based on their responsiveness to ESA: low response group, moderate response group, and good response group. The period from initiation of ESA administration to renal death was significantly shorter in the poor responder group than in the good and moderate responder groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Not provided

Exclusion Criteria

Patients complicated with serious diseases such as malignancy, heart failure (NYHA III degrees or more), and liver cirrhosis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of anemia on renal prognosis in CKD patients
Secondary Outcome Measures
NameTimeMethod
Impact of anemia in CKD patients on life prognosis
© Copyright 2025. All Rights Reserved by MedPath